These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33179154)

  • 1. Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
    Lugtenberg RT; de Groot S; Kaptein AA; Fischer MJ; Kranenbarg EM; Carpentier MD; Cohen D; de Graaf H; Heijns JB; Portielje JEA; van de Wouw AJ; Imholz ALT; Kessels LW; Vrijaldenhoven S; Baars A; Fiocco M; van der Hoeven JJM; Gelderblom H; Longo VD; Pijl H; Kroep JR;
    Breast Cancer Res Treat; 2021 Feb; 185(3):741-758. PubMed ID: 33179154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
    de Groot S; Lugtenberg RT; Cohen D; Welters MJP; Ehsan I; Vreeswijk MPG; Smit VTHBM; de Graaf H; Heijns JB; Portielje JEA; van de Wouw AJ; Imholz ALT; Kessels LW; Vrijaldenhoven S; Baars A; Kranenbarg EM; Carpentier MD; Putter H; van der Hoeven JJM; Nortier JWR; Longo VD; Pijl H; Kroep JR;
    Nat Commun; 2020 Jun; 11(1):3083. PubMed ID: 32576828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.
    Fischer MJ; Inoue K; Matsuda A; Kroep JR; Nagai S; Tozuka K; Momiyama M; Weijl NI; Langemeijer-Bosman D; Ramai SRS; Nortier JWR; Putter H; Yamaoka K; Kubota K; Kobayashi K; Kaptein AA
    Breast Cancer Res Treat; 2017 Nov; 166(2):459-471. PubMed ID: 28762012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
    Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
    J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
    Conte P; Schneeweiss A; Loibl S; Mamounas EP; von Minckwitz G; Mano MS; Untch M; Huang CS; Wolmark N; Rastogi P; D'Hondt V; Redondo A; Stamatovic L; Bonnefoi H; Castro-Salguero H; Fischer HH; Wahl T; Song C; Boulet T; Trask P; Geyer CE
    Cancer; 2020 Jul; 126(13):3132-3139. PubMed ID: 32286687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in patients with breast cancer surgery and undergoing chemotherapy in Ahmednagar district.
    Kshirsagar AS; Wani SK
    J Cancer Res Ther; 2021; 17(6):1335-1338. PubMed ID: 34916362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life with talazoparib versus physician's choice of chemotherapy in patients with advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA phase III trial.
    Ettl J; Quek RGW; Lee KH; Rugo HS; Hurvitz S; Gonçalves A; Fehrenbacher L; Yerushalmi R; Mina LA; Martin M; Roché H; Im YH; Markova D; Bhattacharyya H; Hannah AL; Eiermann W; Blum JL; Litton JK
    Ann Oncol; 2018 Sep; 29(9):1939-1947. PubMed ID: 30124753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
    Schwartzberg L; McIntyre K; Wilks S; Puhalla S; O'Shaughnessy J; Berrak E; He Y; Vahdat L
    BMC Cancer; 2019 Jun; 19(1):578. PubMed ID: 31195996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles.
    Sultan A; Choudhary V; Parganiha A
    Chronobiol Int; 2017; 34(5):609-623. PubMed ID: 28276853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer.
    Osoba D; Zee B; Pater J; Warr D; Kaizer L; Latreille J
    Qual Life Res; 1994 Oct; 3(5):353-64. PubMed ID: 7841968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Hassen AM; Taye G; Gizaw M; Hussien FM
    PLoS One; 2019; 14(9):e0222629. PubMed ID: 31539399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
    Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
    Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.
    Gwark S; Ahn SH; Noh WC; Lee ES; Jung Y; Kim LS; Han W; Nam SJ; Gong G; Kim SO; Kim HJ
    Front Oncol; 2021; 11():608207. PubMed ID: 34277393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
    Iwase S; Kawaguchi T; Yotsumoto D; Doi T; Miyara K; Odagiri H; Kitamura K; Ariyoshi K; Miyaji T; Ishiki H; Inoue K; Tsutsumi C; Sagara Y; Yamaguchi T
    Support Care Cancer; 2016 Feb; 24(2):637-646. PubMed ID: 26105516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
    Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
    Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1 and Insulin Receptor Single Nucleotide Variants Associated with Response in HER2-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without a Fasting Mimicking Diet (BOOG 2013-04 DIRECT Trial).
    de Gruil N; Böhringer S; de Groot S; Pijl H; Kroep JR; Swen JJ
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.